COMPUMEDICS LTD’S DAVID BURTON TALKS PROFITABLE REVENUE GROWTH IN PROACTIVE Q&A SESSIONS
Compumedics Ltd’s (ASX:CMP) David Burton, chairman and CEO, will exclusively join Proactive Q&A Sessions in a four-part interview series.
Compumedics is an innovative developer and manufacturer of medical devices for sleep, brain and ultrasonic blood-flow monitoring applications.
Today’s interview will focus on: Revenue Growth & Peer Valuation; Revenue Roadmap; and Product Integration Growth Platform.
-29th June : Next Generation Growth; Core and Step-out.
-6th July: Customer Engagement, Acquisition and Retention Strategy
-13th July : China, Asia and Beyond.
To read the transcript of today’s Proactive Q&A Sessions, please click here to download the PDF